RUNX1 and breast carcinoma: Interestingly, Ferrari and colleagues have shown using multivariate analysis that high expression of RUNX1 correlates with poor prognosis in triple negative human breast cancer and strongly suggest that Runx1 could be used as an independent prognostic marker in this subgroup of human breast cancer [13].